{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:03:12Z","timestamp":1773961392509,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cca.2025.120801","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T22:52:28Z","timestamp":1767307948000},"page":"120801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rheumatoid arthritis: emerging genetic and immunologic biomarkers"],"prefix":"10.1016","volume":"582","author":[{"given":"Seyed Moein","family":"Mahini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keihan","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Irandoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Samare-Najaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Karim","family":"Azadbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0005","article-title":"The role of the microbiome in rheumatoid arthritis: a review","volume":"7","author":"Tsetseri","year":"2023","journal-title":"Rheumatol. Adv. Pract."},{"issue":"7","key":"10.1016\/j.cca.2025.120801_bb0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/microorganisms12071387","article-title":"Exploring the Role of the Microbiome in Rheumatoid Arthritis\u2014A Critical Review","volume":"12","author":"Ermencheva","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.cca.2025.120801_bb0015","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Aletaha d, McInnes IB. rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"10086","key":"10.1016\/j.cca.2025.120801_bb0020","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2025.120801_bb0025","series-title":"Mosaic of Autoimmunity","first-page":"501","article-title":"Chapter 46 - Rheumatoid Arthritis","author":"Alivernini","year":"2019"},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0030","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2025.120801_bb0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fimmu.2019.01353","article-title":"CTHRC1: a new candidate biomarker for improved rheumatoid arthritis diagnosis","volume":"10","author":"Myngbay","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cca.2025.120801_bb0040","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3390\/ijms21114015","article-title":"Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120801_bb0045","article-title":"A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis","volume":"41","author":"Nelson","year":"2024","journal-title":"Pract. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0050","first-page":"317","article-title":"Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine","volume":"115","author":"Bray","year":"2016","journal-title":"WMJ"},{"key":"10.1016\/j.cca.2025.120801_bb0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijbiomac.2017.12.075","article-title":"Proteomics analysis reveals differential pattern of widespread protein expression and novel role of histidine-rich glycoprotein and lipopolysaccharide-binding protein in rheumatoid arthritis","volume":"109","author":"Kim","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0060","doi-asserted-by":"crossref","first-page":"1800011","DOI":"10.1002\/prca.201800011","article-title":"Proteomics analysis for verification of rheumatoid arthritis biomarker candidates using multiple reaction monitoring","volume":"13","author":"Lee","year":"2019","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.cca.2025.120801_bb0065","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.12659\/MSM.895116","article-title":"Xiang, c. research, Serum levels of IL-6 and TNF-\u03b1 may correlate with activity and severity of rheumatoid arthritis","volume":"21","author":"Wei","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0070","first-page":"249","article-title":"Evaluating the Relationship Between Serum Level of Interleukin-6 and Rheumatoid Arthritis Severity and Disease Activity","volume":"16","author":"Rajaei","year":"2020","journal-title":"Curr. Rheumatol. Rev."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"T. therapy, the IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejr.2020.02.009","article-title":"Serum and synovial fluid interleukin-17 concentrations in rheumatoid arthritis patients: Relation to disease activity, radiographic severity and power Doppler ultrasound","volume":"42","author":"Farag","year":"2020","journal-title":"Egypt. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejr.2015.01.001","article-title":"Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity","volume":"38","author":"Al-Saadany","year":"2016","journal-title":"Egypt. Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194883","article-title":"IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis","volume":"13","author":"Dhaouadi","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/1110-161X.168164","article-title":"Interleukin-17 level in rheumatoid arthritis patients and its relation to disease activity: a clinical and ultrasound study","volume":"42","author":"Elhewala","year":"2015","journal-title":"Egypt. Rheumatol. Rehabil."},{"key":"10.1016\/j.cca.2025.120801_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2018.12.001","article-title":"G.F. reviews, Interleukin-13: A promising therapeutic target for autoimmune disease","volume":"45","author":"Mao","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0105","article-title":"Petrescu, The relationship of cytokines IL\u201013 and IL\u201017 with autoantibodies profile in early rheumatoid arthritis","volume":"2016","author":"Silo\u015fi","year":"2016","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1620\/tjem.237.77","article-title":"Low Serum Levels of Interleukin 35 in Patients with Rheumatoid Arthritis","volume":"237","author":"Ning","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0115","first-page":"5366","article-title":"T. medicine, Decreased regulatory T\u2011cell frequency and interleukin\u201135 levels in patients with rheumatoid arthritis","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp Ther Med."},{"issue":"8","key":"10.1016\/j.cca.2025.120801_bb0120","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/keu528","article-title":"Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis","volume":"54","author":"Nakano","year":"2015","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1684\/ecn.2023.0491","article-title":"Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer","volume":"34","author":"Haghshenas","year":"2023","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0130","article-title":"Xia, Plasma interleukin\u201037 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1\/Th2\/Th17\u2010related cytokines","volume":"2015","author":"Xia","year":"2015","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/1756-185X.13539","article-title":"Xu, Elevated expression of interleukin\u201037 in patients with rheumatoid arthritis","volume":"22","author":"Yuan","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2025.120801_bb0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cyto.2018.07.027","article-title":"Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients","volume":"113","author":"Ragab","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2025.120801_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","article-title":"Plasma interleukin-38 in patients with rheumatoid arthritis","volume":"65","author":"Xu","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40744-024-00640-x","article-title":"Emerging Role of Interleukin-38 (IL-38) in the Development of Rheumatoid Arthritis","volume":"11","author":"Liang","year":"2024","journal-title":"Rheumatol. Ther."},{"issue":"10","key":"10.1016\/j.cca.2025.120801_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00296-025-05992-3","article-title":"Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis","volume":"45","author":"Nakaphan","year":"2025","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0160","first-page":"20","article-title":"Anti-RA33 antibody is more sensitive than anti-citrullinated protein antibody in diagnosis of rheumatoid arthritis","volume":"11","author":"Alattabi","year":"2020","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"S5","key":"10.1016\/j.cca.2025.120801_bb0165","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.53730\/ijhs.v6nS5.9829","article-title":"Assessment of auto-antibodies (RF, Anti-CCP, and anti-RA33) in rheumatoid arthritis patients: Comparative study","volume":"6","author":"Hashiam","year":"2022","journal-title":"Int. J. Health Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0170","first-page":"259","article-title":"Diagnostic performance of anti-RA33 antibody as a serological marker for rheumatoid arthritis","volume":"41","author":"Suhail","year":"2019","journal-title":"Malays. J. Pathol."},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00393-016-0134-y","article-title":"Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis","volume":"76","author":"Lee","year":"2017","journal-title":"Z. Rheumatol."},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0180","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/kead545","article-title":"Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis","volume":"63","author":"Zhang","year":"2024","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0185","first-page":"405","article-title":"Diagnostic value of BiP or anti-BiP antibodies for rheumatoid arthritis: A meta-analysis","volume":"36","author":"Liu","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.cca.2025.120801_bb0190","article-title":"Implementation OF Anti-Bip Antibodies as A Novel Biomarker in the Diagnosis OF Rheumatoid Arthritis","volume":"11","author":"Al-Joubouri","year":"2025","journal-title":"Int. J. Dent. Med."},{"key":"10.1016\/j.cca.2025.120801_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117824","article-title":"Prostate cancer: Novel genetic and immunologic biomarkers","volume":"555","author":"Samare-Najaf","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120801_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102438","article-title":"Clinical significance of miRNAs in autoimmunity","volume":"109","author":"Zhang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2025.120801_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120555","article-title":"Immunologic and genetic biomarkers in acute pancreatitis","volume":"578","author":"Younesi","year":"2026","journal-title":"Clin. Chim. Acta"},{"issue":"31","key":"10.1016\/j.cca.2025.120801_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001326","article-title":"Role of micro RNAs in the pathogenesis of rheumatoid arthritis: novel perspectives based on review of the literature","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.cca.2025.120801_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1152\/physiolgenomics.00142.2010","article-title":"A mini-review: microRNA in arthritis","volume":"43","author":"Nakasa","year":"2011","journal-title":"Physiol. Genomics"},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000525112","article-title":"Upregulated miR-146a expression in peripheral blood relates to Th17 and treg imbalance in elder rheumatoid arthritis patients","volume":"15","author":"Liu","year":"2022","journal-title":"Lifestyle Genom."},{"key":"10.1016\/j.cca.2025.120801_bb0225","article-title":"Plasma expression and bioinformatic analysis of Mir-16, Mir-132, Mir-146 and Mir-223 in patients with rheumatoid arthritis","volume":"42","author":"Raslan","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cca.2025.120801_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-020-00199-7","article-title":"Serum a proliferation-inducing ligand and MicroRNA-223 are associated with rheumatoid arthritis: diagnostic and prognostic implications","volume":"26","author":"Taha","year":"2020","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0235","first-page":"326","article-title":"M.J.I.j.o.a. Ghadami, asthma, immunology, Plasma levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as potential diagnostic biomarkers for rheumatoid arthris","volume":"20","author":"Safari","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0240","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/cei.13156","article-title":"Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis","volume":"193","author":"Dunaeva","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13075-015-0555-z","article-title":"Rodriguez-Ariza, therapy, Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF\u03b1","volume":"17","author":"Castro-Villegas","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0250","first-page":"354","article-title":"Comparison of plasma levels of microRNA-155-5p, microRNA-210-3p, and microRNA-16-5p in rheumatoid arthritis patients with healthy controls in a case-control study","volume":"22","author":"Mohebi","year":"2023","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s12276-022-00751-x","article-title":"Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes","volume":"54","author":"Wu","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s13018-023-03797-3","article-title":"Research, MicroRNA-345-3p is a potential biomarker and ameliorates rheumatoid arthritis by reducing the release of proinflammatory cytokines","volume":"18","author":"Ma","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.cca.2025.120801_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790880","article-title":"A serum biomarker panel of exomiR-451a, exomiR-25-3p and soluble TWEAK for early diagnosis of rheumatoid arthritis","volume":"12","author":"Rodr\u00edguez-Muguruza","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0270","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41598-024-82339-1","article-title":"Expression profiles of miR-101-3p and miR-431-5p as potential diagnostic biomarkers for rheumatoid arthritis","volume":"15","author":"Sadaty","year":"2025","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cca.2025.120801_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14651","article-title":"Serum miR\u2010224, miR\u2010760, miR\u2010483\u20105p, miR\u2010378 and miR\u2010375 as potential novel biomarkers in rheumatoid arthritis","volume":"75","author":"Abdelaleem","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.cca.2025.120801_bb0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.55563\/clinexprheumatol\/4me6tg","article-title":"Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis","volume":"40","author":"Tang","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.21873\/cgp.20027","article-title":"Long Non-coding RNAs and their Role in Metastasis","volume":"14","author":"Weidle","year":"2017","journal-title":"CANCER GENOMICS PROTEOMICS"},{"key":"10.1016\/j.cca.2025.120801_bb0295","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2022.11.013","article-title":"Non-invasive diagnosis of endometriosis: Immunologic and genetic markers","volume":"538","author":"Moein Mahini","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120801_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.807738","article-title":"LncRNAs and rheumatoid arthritis: from identifying mechanisms to clinical investigation","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120801_bb0305","article-title":"Emerging role of lncRNAs in osteoarthritis: An updated review","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120801_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773171","article-title":"The emerging role of non-coding RNAs in osteoarthritis","volume":"12","author":"Ghafouri-Fard","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12920-024-01993-6","article-title":"Serum lncRNA ITGB2-AS1 and ICAM-1 as novel biomarkers for rheumatoid arthritis and osteoarthritis diagnosis","volume":"17","author":"Selim","year":"2024","journal-title":"BMC Med. Genom."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0320","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10238-024-01343-x","article-title":"A novel diagnostic model based on lncRNA PTPRE expression, neutrophil count and red blood cell distribution width for diagnosis of seronegative rheumatoid arthritis","volume":"24","author":"Xia","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cca.2025.120801_bb0325","doi-asserted-by":"crossref","first-page":"1419683","DOI":"10.3389\/fimmu.2024.1419683","article-title":"Serum exosomes lncRNAs: TCONS_I2_00013502 and ENST00000363624 are new diagnostic markers for rheumatoid arthritis","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jir.2018.0117","article-title":"Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients","volume":"39","author":"Shaker","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cca.2025.120801_bb0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10238-013-0271-4","article-title":"PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis","volume":"15","author":"Song","year":"2015","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cca.2025.120801_bb0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42358-024-00349-z","article-title":"Clinical significance of long non-coding RNA NORAD in rheumatoid arthritis","volume":"64","author":"Zhao","year":"2024","journal-title":"Adv. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0345","doi-asserted-by":"crossref","first-page":"6401978","DOI":"10.1155\/2020\/6401978","article-title":"Elevated expression of the long noncoding RNA IFNG\u2010AS1 in the peripheral blood from patients with rheumatoid arthritis","volume":"2020","author":"Peng","year":"2020","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.cca.2025.120801_bb0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/br.2021.1469","article-title":"Diagnostic role of lncRNA GAS5 and its genetic polymorphisms rs2067079, rs6790 and rs17359906 in rheumatoid arthritis","volume":"15","author":"Elamir","year":"2021","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0355","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09674845.2020.1744942","article-title":"Serum LINC00305 expression and its genetic variant rs2850711 are associated with clinical and laboratory features of rheumatoid arthritis","volume":"77","author":"Wahba","year":"2020","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.cca.2025.120801_bb0360","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtn.2020.11.008","article-title":"Circular RNA: an important player with multiple facets to regulate its parental gene expression","volume":"23","author":"Shao","year":"2021","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.cca.2025.120801_bb0365","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2019.00639","article-title":"Roles of CircRNAs in autoimmune diseases","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0370","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jpp\/rgac096","article-title":"Circular RNA in autoimmune diseases: special emphasis on regulation mechanism in RA and SLE","volume":"75","author":"Huang","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0375","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.13181","article-title":"Identification of circular RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for rheumatoid arthritis","volume":"194","author":"Luo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0380","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08916934.2021.1922891","article-title":"Circular RNAs hsa-circ0000175 and hsa-circ0044235 in plasma are novel biomarkers for new-onset rheumatoid arthritis","volume":"54","author":"Gao","year":"2021","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.cca.2025.120801_bb0385","first-page":"1203","article-title":"Li, Expression and clinical significance of circular RNAs hsa_circ_0000175 and hsa_circ_0008410 in peripheral blood mononuclear cells from patients with rheumatoid arthritis","volume":"45","author":"Luo","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cca.2025.120801_bb0390","doi-asserted-by":"crossref","first-page":"2073139","DOI":"10.1155\/2019\/2073139","article-title":"Circular RNAs Hsa_circ_0002715 and Hsa_circ_0035197 in Peripheral Blood Are Novel Potential Biomarkers for New-Onset Rheumatoid Arthritis","volume":"2019","author":"Luo","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cca.2025.120801_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-021-02794-8","article-title":"Identification of circular RNAs hsa_circ_0140271 in peripheral blood mononuclear cells as a novel diagnostic biomarker for female rheumatoid arthritis","volume":"16","author":"Chen","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0400","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3892\/mmr.2021.12256","article-title":"circPTPN22 as a novel biomarker and ceRNA in peripheral blood mononuclear cells of rheumatoid arthritis","volume":"24","author":"Jiang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2025.120801_bb0405","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2147\/IJGM.S309436","article-title":"Correlation between level of interleukin-37 and rheumatoid arthritis progression","author":"Zhu","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"11","key":"10.1016\/j.cca.2025.120801_bb0410","first-page":"2109","article-title":"Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis","volume":"40","author":"Wu","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0415","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12920-023-01635-3","article-title":"Association of integrin-\u03b22 polymorphism and expression with the risk of rheumatoid arthritis and osteoarthritis in Egyptian patients","volume":"16","author":"Selim","year":"2023","journal-title":"BMC Med. Genom."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0420","doi-asserted-by":"crossref","first-page":"5735279","DOI":"10.1155\/2020\/5735279","article-title":"Decreased ALKBH5, FTO, and YTHDF2 in peripheral blood are as risk factors for rheumatoid arthritis","volume":"2020","author":"Luo","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2025.120801_bb0425","doi-asserted-by":"crossref","first-page":"1087279","DOI":"10.3389\/fimmu.2022.1087279","article-title":"DNA methylation change of HIPK3 in Chinese rheumatoid arthritis and its effect on inflammation","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.cca.2025.120801_bb0430","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/cells12192376","article-title":"DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms","volume":"12","author":"Pitaksalee","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.902","article-title":"Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis","volume":"11","author":"Shi","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0440","first-page":"967","article-title":"Comparison of Serum Nesfatin-1 and Visfatin Levels Between Patients with Rheumatoid Arthritis and Healthy Controls, Osmangazi","volume":"46","author":"G\u00fccenmez","year":"2024","journal-title":"J. Med."},{"key":"10.1016\/j.cca.2025.120801_bb0445","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.2147\/IJGM.S330099","article-title":"Elevated nesfatin-1 level in synovium and synovial fluid is associated with pro-inflammatory cytokines in patients with rheumatoid arthritis","author":"Zhang","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120801_bb0450","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.13038","article-title":"Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta\u2010analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2025.120801_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763832","article-title":"Proteoform Analysis of Matrix Metalloproteinase-9\/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids","volume":"12","author":"Grillet","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0460","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/medicina59010167","article-title":"Matrix Metalloproteinase-9 Level in Synovial Fluid\u2014Association with Joint Destruction in Early Rheumatoid Arthritis","volume":"59","author":"Stojanovic","year":"2023","journal-title":"Medicina"},{"issue":"9","key":"10.1016\/j.cca.2025.120801_bb0465","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/diagnostics13091653","article-title":"MMP-13, VEGF, and Disease Activity in a Cohort of Rheumatoid Arthritis Patients","volume":"13","author":"Boldeanu","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejr.2021.07.003","article-title":"Collagen triple helix repeat containing 1 (CTHRC1) protein: A promising biomarker for evaluation of rheumatoid arthritis patients","volume":"44","author":"Selim","year":"2022","journal-title":"Egypt. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0475","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/09674845.2020.1810400","article-title":"Value of serum collagen triple helix repeat containing-1 (CTHRC1) and 14-3-3\u03b7 protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis","volume":"78","author":"Hu","year":"2021","journal-title":"Br. J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.cca.2025.120801_bb0480","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/reum.2020.95359","article-title":"Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis","volume":"58","author":"Ali","year":"2020","journal-title":"Reumatologia"},{"issue":"9","key":"10.1016\/j.cca.2025.120801_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255854","article-title":"Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis","volume":"16","author":"Gonzalez-Ponce","year":"2021","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.cca.2025.120801_bb0490","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026504","article-title":"Increased hexokinase-2 as a novel biomarker for the diagnosis and correlating with disease severity in rheumatoid arthritis","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.cca.2025.120801_bb0495","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/1756-185X.13921","article-title":"Mo, Diagnostic accuracy of 14\u20103\u20103 \u03b7 protein in rheumatoid arthritis: a meta\u2010analysis","volume":"23","author":"Wang","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0500","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13075-015-0799-7","article-title":"Tanaka, therapy, Serum 14-3-3\u03b7 level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab","volume":"17","author":"Hirata","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.cca.2025.120801_bb0505","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5114\/reum.2022.123669","article-title":"14-3-3\u03b7 protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis","volume":"60","author":"Adel","year":"2022","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0510","first-page":"57","article-title":"Serum 14-3-3\u03b7 could improve the diagnostic rate of rheumatoid arthritis and correlates to disease activity","volume":"49","author":"Guan","year":"2019","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0515","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-020-15700-3","article-title":"Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study","volume":"11","author":"Hu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0520","doi-asserted-by":"crossref","first-page":"eadr8078","DOI":"10.1126\/sciadv.adr8078","article-title":"Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis","volume":"11","author":"Xie","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cca.2025.120801_bb0525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13075-020-02405-7","article-title":"Therapy, Serum biomarker panel for the diagnosis of rheumatoid arthritis","volume":"23","author":"Mun","year":"2021","journal-title":"Arthritis Res. Ther."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:06:25Z","timestamp":1773950785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":105,"alternative-id":["S0009898125006801"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120801","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis: emerging genetic and immunologic biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120801"}}